Lung Cancer Clinical Trial
Official title:
Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography (LDCT)- a Screening Program
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis
of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought
to be the best screening tool for lung cancer. However, there is growing concerns about
radiation exposure, high cost, and high rate of false-positive screening result.
Epidemiologic studies from western countries showed that cigarette smoking is the major cause
of lung cancer, and other risk factors may include age, environmental pollution, occupational
exposures (included of radon exposure), gender, race, and pre-existing lung diseases.
Adenocarcinoma is the major type of lung cancer in Taiwan and is less attributable to
smoking. The investigators need a different risk prediction model adapted to the
investigators country.
National Taiwan University Hospital Chu-Tung Branch initiated the lung cancer screening by
LDCT since June 2015. Many people can get the LDCT screening with affordable price with the
subsidy from enterprise donation. The purpose of this study is observing those participants
with 2-year follow-up. Furthermore, those data may connect with another study of "Low dose
computed tomography screening study in nonsmoker with risk factors for lung cancer in Taiwan"
(Non-smoker study)which is implemented in other hospitals in Taiwan.For reality limiting,
After one year, the enrollment rate was a lot lower than expected. We extended the enrollment
time but only observe those participants for one year not two year..
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis
of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought
to be the best screening tool for lung cancer. However, there is growing concerns about
radiation exposure, high cost, and high rate of false-positive screening result.
Epidemiologic studies from western countries showed that cigarette smoking is the major cause
of lung cancer, and other risk factors may include age, environmental pollution, occupational
exposures (included of radon exposure), gender, race, and pre-existing lung diseases.
Adenocarcinoma is the major type of lung cancer in Taiwan and is less attributable to
smoking. The investigators need a different risk prediction model adapted to the
investigators country.
National Taiwan University Hospital Chu-Tung Branch initiated the lung cancer screening by
LDCT since June 2015. Many people can get the LDCT screening with affordable price with the
subsidy from enterprise donation. The purpose of this study is observing those participants
with 2-year follow-up. Furthermore, those data may connect with another study of "Low dose
computed tomography screening study in nonsmoker with risk factors for lung cancer in Taiwan"
(Non-smoker study)which is implemented in other hospitals in Taiwan.
Aim 1: Being the control group of the non-smoker study, the investigators collect the
relevant information from participants to validate and modify their risk assessment model.
Applying the same the questionnaires of the non-smoker study and results of LDCT screening in
different population. All data could provide extra information to improve their risk
prediction model for predicting lung cancer in non-smokers in Taiwan.
Aim 2: To establish the local epidemiological data for lung pathology. From the baseline
data, screening results of LDCT, telephone follow up on questionable lesions, collection of
patient's medical records, and linkage to National Health Insurance Database, the
investigators will be able to establish local epidemiology data on lung pathology as well as
information on screening accuracy of LDCT.
Aim 3: To examine the psychosocial impacts and health behaviors of the participants receiving
LDCT. Questionnaire surveys provide the understanding of anxiety and life quality at several
time points since LDCT screening. The study was to investigate whether the screening results
were associated with health behaviors change, such as smoking, drinking, and exercise.
With low enrollment rate in first year, we decided to extend the enrollment period. But we
only observed those participants for one year, not 2 year. So far we carry on the analysis
and the discussion.
Keywords: Lung cancer, Low dose computed tomography, screening, health behavior,
psychological factors.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|